Benefícios cardiovasculares dos agonistas do receptor do peptídio-1 glucagon-like (GLP-1) em pacientes com diabetes melito tipo 2: evidência de amplos estudos multinacionais.

The Time-varying Cardiovascular benefits of Glucagon like peptide-1 receptor agonist therapy in patients with type 2 Diabetes Mellitus: Evidence from large multinational trials – Diabetes, Obesity & Metabolism

Comentário: Survival time analysis shows CV benefits of GLP1 receptor agonists – medwireNews